RPG Life Sciences is currently trading at Rs 82.45, up by 0.85 points or 1.04% from its previous closing of Rs 81.60 on the BSE.
The scrip opened at Rs 82.20 and has touched a high and low of Rs 82.95 and Rs 81.65 respectively. So far 376 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 8 has touched a 52 week high of Rs 122.00 on 05-Nov-2010 and a 52 week low of Rs 62.20 on 08-Dec-2010.
Last one week high and low of the scrip stood at Rs 84.00 and Rs. 76.15 respectively. The current market cap of the company is Rs 134.93 crore.
The promoters holding in the company stood at 52.02% while Institutions and Non-Institutions held 2.90% and 45.09% respectively.
Credit rating agency, CARE has revised the rating assigned to the bank facilities of RPG Life Sciences. The agency has revised the assigned ‘BBB-‘rating to ‘BBB’ to the long-term bank facilities of the company amounting Rs 25.33 crore. The agency has also revised the assigned ‘A3’ rating to ‘A3+’ to the short-term bank facilities of the company amounting Rs 40.92 crore.
Further, the agency has also revised the assigned ‘BBB-/A3’ rating to ‘BBB/A3+’ to the long-term/short-term bank facilities of the company amounting Rs 23.70 crore. However, the ratings continue to be constrained by the relatively small size of operations coupled with moderate liquidity indicators and gearing ratios. The company’s ability to achieve the projected sales and profitability together with receipt of USFDA approval remains the key rating sensitivities.
RPG Lifesciences (RPGLS), part of the RPG group, is a pharmaceutical company, engaged in manufacturing of Synthetic APIs, Biotech APIs and Formulations under its own brand name and contract manufacturing for large pharma companies. The company’s manufacturing facilities are located at Ankleshwar, Gujarat and Thane, Maharashtra.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1777.65 |
| Dr. Reddys Lab | 1194.55 |
| Cipla | 1465.65 |
| Lupin | 2043.30 |
| Zydus Lifesciences | 944.25 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
FREE Become a savvy and confident
stock investor.
Hurry, limited to the first 10 users today!
Download APP
